Abstract
Cancer cells require a steady source of metabolic energy in order to continue their uncontrolled growth and proliferation. Accelerated glycolysis is one of the biochemical characteristics of cancer cells. Recent work indicates that glucose transport and metabolism are essential for the posttreatment survival of tumor cells, leading to poor prognosis. Glycolytic breakdown of glucose is preceded by the transport of glucose across the cell membrane, a rate-limiting process mediated by facilitative glucose transporter proteins belonging to the facilitative glucose transporter/solute carrier GLUT/SLC2A family. Tumors frequently show overexpression of GLUTs, especially the hypoxia-responsive GLUT1 and GLUT3 proteins. There are also studies that have reported associations between GLUT expression and proliferative indices, whilst others suggest that GLUT expression may be of prognostic significance. In this article we revisit Warburg’s original hypothesis and review the recent clinical and basic research on the expression of GLUT family members in human cancers and in cell lines derived from human tumors. We also explore the links between hypoxia-induced genes, glucose transporters and angiogenic factors. Hypoxic tumors are significantly more malignant, metastatic, radio- and chemoresistant and have a poor prognosis. With the discovery the oxygen-sensitive transcription factor hypoxia-inducible factor (HIF-1) has come a new understanding of the molecular link between hypoxia and deregulated glucose metabolism. HIF-1 induces a number of genes integral to angiogenesis, e.g. vascular endothelial growth factor (VEGF), a process intimately involved with metastatic spread. This knowledge may enhance existing chemotherapeutic strategies so that treatment can be more rationally applied and personalized for cancer patients.
References
134
Referenced
262
10.2307%2F2530600
10.1016%2F0278-6915%2886%2990346-7
10.1016%2Fj.canlet.2004.02.009
10.1093%2Fcarcin%2F21.3.497
10.1126%2Fscience.123.3191.309
10.4067%2FS0716-97602002000100004
10.1016%2Fj.ejca.2003.10.024
10.1007%2FBF02904704
10.1007%2Fs00259-005-0044-8
10.1016%2F0197-0186%2893%2990004-O
10.1079%2FBJN2002763
10.1080%2F09687680110090456
10.1111%2Fj.1432-1033.1994.tb18550.x
10.1080%2F09687680110100995
10.1016%2F0006-291X%2892%2992362-2
10.1210%2Fen.132.6.2538
10.1073%2Fpnas.86.8.2535
10.1093%2Femboj%2F20.16.4467
10.1006%2Fgeno.2002.7010
10.1046%2Fj.1440-1827.2002.01368.x
10.1007%2Fs00066-003-1150-9
10.1002%2F1097-0142%2819931115%2972%3A10%3C2979%3A%3AAID-CNCR2820721020%3E3.0.CO%3B2-X
10.1309%2F5Y2L-CDCK-YB55-KDK6
10.1073%2Fpnas.93.5.1847
10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C34%3A%3AAID-CNCR5%3E3.0.CO%3B2-E
10.1159%2F000055314
10.1038%2Fsj.bjc.6601202
10.1002%2Fijc.2910560503
10.1002%2Fcncr.11159
10.1002%2F%28SICI%291097-0142%2819970915%2980%3A6%3C1046%3A%3AAID-CNCR6%3E3.0.CO%3B2-7
10.1016%2FS0169-5002%2802%2900108-3
10.1002%2F1097-0142%2820010801%2992%3A3%3C634%3A%3AAID-CNCR1364%3E3.0.CO%3B2-X
10.1089%2F105072502760339307
10.1016%2F0169-328X%2894%2990183-X
10.1023%2FA%3A1026466229242
10.1002%2Fcncr.10280
10.1006%2Fgyno.2000.5910
10.1002%2F1097-0142%2820010901%2992%3A5%3C1144%3A%3AAID-CNCR1432%3E3.0.CO%3B2-T
10.1016%2F0006-291X%2890%2991263-R
10.1097%2F00005537-200202000-00034
10.1080%2F09553009214552291
10.1002%2F%28SICI%291097-0142%2820000115%2988%3A2%3C381%3A%3AAID-CNCR20%3E3.0.CO%3B2-M
10.1002%2Fijc.1336
10.1054%2Fbjoc.2000.1305
10.1126%2Fscience.3839598
10.1016%2F0167-8140%2893%2990025-4
10.1634%2Ftheoncologist.7-6-492
10.1016%2FS0167-8140%2898%2900044-9
10.2307%2F3574011
10.1269%2Fjrr.43.161
10.1097%2F00001813-200101000-00001
10.1007%2FBF00689633
10.1016%2F0014-5793%2879%2981037-6
10.1093%2Fjnci%2F93.4.266
10.1080%2F028418699432590
10.1054%2Fdrup.2000.0120
10.1054%2Fbjoc.2000.1564
10.3109%2F02841869609100716
10.1016%2FS1053-4296%2896%2980033-6
10.1053%2Fsrao.2003.50008
10.1073%2Fpnas.94.9.4273
10.1073%2Fpnas.95.14.7987
10.1074%2Fjbc.271.50.32253
10.1074%2Fjbc.271.51.32529
10.1073%2Fpnas.94.15.8104
10.1038%2Fsj.onc.1205047
10.1006%2Fabbi.1996.0469
10.1074%2Fjbc.271.48.30392
10.1016%2F0005-2736%2889%2990205-8
10.1023%2FA%3A1022446730452
10.1074%2Fjbc.C000023200
10.1016%2FS0014-5793%2897%2900340-2
10.1074%2Fjbc.M010144200
10.1259%2F0007-1285-64-760-350
10.1128%2FMCB.21.10.3436-3444.2001
10.1074%2Fjbc.272.9.5555
10.1016%2FS0272-6386%2899%2970131-9
10.1021%2Fbi00447a011
10.1021%2Fbi961208t
10.1006%2Fbbrc.1999.1040
10.1200%2FJCO.20.2.379
10.1016%2FS0006-2952%2802%2901160-7
10.1210%2Fen.142.6.2707
10.1038%2Fsj.gt.3301702
10.1016%2FS0360-3016%2898%2900323-X
10.1016%2F0360-3016%2896%2900132-0
10.1016%2FS0360-3016%2898%2900004-2
10.1038%2Fsj.bjc.6690700
10.1159%2F000088950
10.1080%2F02841860152708198
10.1006%2Fgyno.1998.5163
10.1016%2FS0167-8140%2897%2901931-2
10.2307%2F3580034
10.1016%2FS0167-8140%2803%2900010-0
10.1016%2FS0360-3016%2800%2901493-0
10.1002%2Fijc.10904
10.2307%2F3579620
10.1054%2Fbjoc.2000.1111
10.1097%2F00006231-199802000-00002
10.1016%2FS0959-8049%2800%2900031-9
10.1016%2FS0969-8051%2897%2900226-6
10.1016%2FS0969-8051%2802%2900288-3
10.1016%2F0969-8051%2894%2990162-7
10.1007%2Fs002590050197
10.1007%2Fs002590050355
10.1097%2F00004424-200305000-00002
10.3816%2FCBC.2003.s.016
10.1016%2FS1095-0397%2800%2900042-X
10.1007%2Fs00259-003-1127-z
10.1097%2F00006231-200108000-00005
10.1097%2F00004424-198705000-00002
10.1016%2FS0959-8049%2800%2900037-X
10.1016%2FS0969-8051%2896%2900134-5
10.1007%2FBF01052932
10.1080%2F028418600750013320
10.1007%2Fs00259-003-1130-4
10.1007%2Fs00259-002-1096-7
10.1016%2FS0969-8043%2802%2900186-0
10.1038%2F19986
10.1016%2FS0006-8993%2801%2902877-3
10.1046%2Fj.1432-1327.1999.00403.x
10.1038%2F364079a0
10.1074%2Fjbc.272.30.18982
10.1074%2Fjbc.M110496200
10.1021%2Fjm991119p
10.1159%2F000238451
10.1016%2FS0046-8177%2800%2980192-6
10.1046%2Fj.1471-4159.1999.0720238.x
10.1074%2Fjbc.M312226200
10.1016%2FS0022-5193%2805%2980200-0
10.1146%2Fannurev.ge.22.120188.002513
10.1146%2Fannurev.cellbio.15.1.551
10.1007%2FBF00268936
10.1016%2F0005-2736%2891%2990139-Y
Dates
Type | When |
---|---|
Created | 18 years, 2 months ago (June 26, 2007, 1:13 a.m.) |
Deposited | 4 months, 1 week ago (April 23, 2025, 10:55 p.m.) |
Indexed | 2 days, 18 hours ago (Sept. 3, 2025, 5:50 a.m.) |
Issued | 18 years, 8 months ago (Jan. 1, 2007) |
Published | 18 years, 8 months ago (Jan. 1, 2007) |
Published Online | 18 years, 2 months ago (June 25, 2007) |
Published Print | 18 years, 8 months ago (Jan. 1, 2007) |
@article{Airley_2007, title={Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics}, volume={53}, ISSN={1421-9794}, url={http://dx.doi.org/10.1159/000104457}, DOI={10.1159/000104457}, number={4}, journal={Chemotherapy}, publisher={S. Karger AG}, author={Airley, Rachel E. and Mobasheri, Ali}, year={2007}, pages={233–256} }